Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
8
8 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- SHR-1918Phase 37 trials
Beijing Suncadia Pharmaceuticals Co., Ltd · Homozygous Familial Hypercholesterolemia, Hyperlipidemia, Hypercholesterolemia
- QLC7401Phase 34 trials
Qilu Pharmaceutical Co., Ltd. · Primary Hypercholesterolemia or Mixed Hyperlipidemia, Heterozygous Familial Hypercholesterolemia (HeFH)
- SYH2053Phase 34 trials
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. · Non-familial Hypercholesterolemia and Mixed Hyperlipidemia, Heterozygous Familial Hypercholesterolemia (HeFH), Hypercholesterolemia and Mixed Hyperlipidemia
- SAL003Phase 32 trials
Shenzhen Salubris Pharmaceuticals Co., Ltd. · Hyperlipidemias, Hypercholesterolemia, Mixed Dyslipidemia, Hyperlipidemias
- IBI306Phase 31 trial
Innovent Biologics (Suzhou) Co. Ltd. · Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia
- HRS-7249Phase 22 trials
Fujian Shengdi Pharmaceutical Co., Ltd. · Hyperlipidemia
- HRS-1301Phase 21 trial
Shandong Suncadia Medicine Co., Ltd. · Hyperlipidemia
- SYH2070Phase 21 trial
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. · Mixed Hyperlipidemia
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.